Rohan Shah

Rohan Shah is a Senior Analyst at Aetion, a healthcare analytics company backed by Warburg Pincus and NEA, since June 2021. Prior to this role, Rohan served as a Research Associate at Stony Brook Medicine from March 2018 to August 2021, where research focused on fatty acid binding proteins and transient receptor potential vanilloid channels in lipid metabolism, development of a preclinical model for total knee arthroplasty in advanced osteoarthritis, and potential FABP inhibitors for pain and inflammatory disorders. Rohan holds a B.S. in Biochemistry from Stony Brook University and an Advanced Regents Diploma from St. Francis Preparatory School.